Bendik Lund
Impact in
-
- Childhood Cancer Survivors' Quality of Life
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Lymphoblastic Leukemia research 19
-
- Childhood Cancer Survivors' Quality of Life 8
- Co-authors
- Kjeld Schmiegelow (18 shared papers)Mats Heyman (11 shared papers)Jonas Abrahamsson (14 shared papers)Ólafur G. Jónsson (8 shared papers)Kathrine Grell (6 shared papers)Jukka Kanerva (5 shared papers)Ólafur Gísli Jónsson (9 shared papers)Goda Vaitkevičienė (11 shared papers)
In The Last Decade
Bendik Lund
27 papers receiving 681 citations
Peers
Comparison fields: 5 of 70
- Pediatrics, Perinatology and Child Health 252
- Public Health, Environmental and Occupational Health 345
- Speech and Hearing 75
- Hematology 126
- Immunology 93
Countries citing papers authored by Bendik Lund
This map shows the geographic impact of Bendik Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bendik Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bendik Lund more than expected).
Fields of papers citing papers by Bendik Lund
This network shows the impact of papers produced by Bendik Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bendik Lund. The network helps show where Bendik Lund may publish in the future.
Co-authors
The 25 scholars most cited alongside Bendik Lund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 95 | |
| 2 | 2010 | 94 | |
| 3 | 2017 | 75 | |
| 4 | 2019 | 68 | |
| 5 | 2020 | 51 | |
| 6 | 2017 | 47 | |
| 7 | 2016 | 45 | |
| 8 | 2018 | 35 | |
| 9 | 2008 | 21 | |
| 10 | 2011 | 19 | |
| 11 | 2020 | 17 | |
| 12 | 2017 | 17 | |
| 13 | Gemcitabine: once-weekly schedule active and better tolerated than twice-weekly schedule. | 1996 | 16 |
| 14 | 2019 | 15 | |
| 15 | 2018 | 13 | |
| 16 | 2018 | 11 | |
| 17 | 2017 | 7 | |
| 18 | 2017 | 7 | |
| 19 | 2021 | 6 | |
| 20 | 2013 | 6 |
About Bendik Lund
Bendik Lund is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Hematology, Molecular Biology and Oncology, having authored 30 papers that have together received 690 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (19 papers), Childhood Cancer Survivors' Quality of Life (8 papers), Adolescent and Pediatric Healthcare (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Protein Tyrosine Phosphatases (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Pediatrics, Perinatology and Child Health (252 citations), Public Health, Environmental and Occupational Health (345 citations), Speech and Hearing (75 citations), Hematology (126 citations) and Immunology (93 citations). Bendik Lund has collaborated with scholars based in Norway, Denmark and Sweden. Frequent co-authors include Kjeld Schmiegelow, Mats Heyman, Jonas Abrahamsson, Ólafur G. Jónsson, Kathrine Grell, Jukka Kanerva, Ólafur Gísli Jónsson, Goda Vaitkevičienė, Birgitte Klug Albertsen and Henrik Hasle. Their work appears in journals such as European Journal Of Haematology, Blood, British Journal of Haematology, Leukemia and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.